【24h】

Invasive disease caused by ciprofloxacin-resistant uropathogenic Escherichia coli.

机译:由环丙沙星耐药的尿路致病性大肠杆菌引起的侵袭性疾病。

获取原文
获取原文并翻译 | 示例
       

摘要

To evaluate the invasiveness of ciprofloxacin-resistant Escherichia coli isolated from the urinary tract, the susceptibility to ciprofloxacin of Escherichia coli strains from patients with invasive urinary tract infection was compared with that of isolates from patients with noninvasive disease. In a 14-month period, 2054 different isolates of Escherichia coli were analyzed, of which 554 (27%) were resistant to ciprofloxacin. One hundred twelve (5.4%) strains were isolated from patients with invasive disease. Resistance was significantly less frequent in isolates from patients with invasive disease (4.5%) than in isolates from patients with noninvasive disease (28.3%) (OR, 0.12; CI 95%, 0.05-0.29; P<0.001). Most ciprofloxacin-resistant strains associated with invasive disease were isolated from bacteremic patients who had recently undergone an invasive procedure involving the urinary tract. Invasive disease is caused more frequently by ciprofloxacin-susceptible strains of Escherichia coli, suggesting that resistance to ciprofloxacin may decrease the invasiveness of uropathogenic Escherichia coli.
机译:为了评估从尿路分离的耐环丙沙星的大肠杆菌的侵袭性,将侵袭性尿路感染患者的大肠杆菌菌株对环丙沙星的敏感性与非侵袭性疾病患者分离株的敏感性进行了比较。在14个月内,分析了2054种不同的大肠杆菌,其中554种(27%)对环丙沙星耐药。从浸润性疾病患者中分离出一百一十二(5.4%)株。侵袭性疾病患者分离株的抗药性(4.5%)明显少于非侵袭性疾病患者分离株的抗药性(28.3%)(OR,0.12; CI 95%,0.05-0.29; P <0.001)。与侵袭性疾病相关的大多数环丙沙星耐药菌株是从近期接受了涉及尿路的侵袭性手术的细菌患者中分离出来的。侵袭性疾病更易由环丙沙星敏感的大肠杆菌引起,这表明对环丙沙星的耐药性可能会降低尿路致病性大肠杆菌的侵袭性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号